Sponsors (14)
Ask me what this bill is really trying to do.
This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Adds a new subsection (hh) to 21 U.S.C. 352 requiring that labeling for the drug mifepristone include a specified warning statement (including a hotline number) printed in conspicuous text.
Adds a new provision (designated as section 1009 under Title X of the Public Health Service Act) establishing a toll-free, 24/7 hotline to provide support for women seeking to reverse the effects of mifepristone and limiting referrals to providers that provide abortion pill reversal services.
This bill would change the label on mifepristone (often called the abortion pill) and set up a 24/7 hotline. The label would have to say that taking natural progesterone may counteract mifepristone’s effects and could raise the chance a pregnancy continues. It would also say that the American Society for Reproductive Medicine has found natural progesterone to be safe in the first trimester, and it would include a phone number for the new hotline. The hotline would give information and make referrals only to providers who offer “abortion pill reversal” services. Mifepristone is a drug approved to end a pregnancy through 10 weeks when used with misoprostol.
Referred to the House Committee on Energy and Commerce.
Introduced January 28, 2025 by Mary E. Miller · Last progress January 28, 2025
Referred to the House Committee on Energy and Commerce.
Introduced in House